Viewing Study NCT06254066


Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2025-12-30 @ 5:34 AM
Study NCT ID: NCT06254066
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-02-12
First Post: 2024-02-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast Cancer
Sponsor: Zhejiang Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module